Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson u.S. Producer Price Index (PPI) — Pharmaceutical Preparation Manufacturing (PCU325412325412)
Federal Reserve Economic Data (FRED)
Latest, Q3 2026
929.06
Period ended Sep 30, 2026
Change on a year earlier
+1.3%
917.42 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
1
FRED (PCU325412325412)
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | U.S. Producer Price Index (PPI) — Pharmaceutical Preparation Manufacturing (PCU325412325412) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 929.06 | +1.3% | FRED (PCU325412325412) ↗ |
| Q2 2026 | Jun 28, 2026 | 926.72 | +1.3% | FRED (PCU325412325412) ↗ |
| Q1 2026 | Mar 29, 2026 | 925.44 | +1.1% | FRED (PCU325412325412) ↗ |
| Q4 2025 | Dec 28, 2025 | 919.12 | +0.1% | FRED (PCU325412325412) ↗ |
| Q3 2025 | Sep 28, 2025 | 917.42 | 0.0% | FRED (PCU325412325412) ↗ |
| Q2 2025 | Jun 29, 2025 | 915.09 | +0.1% | FRED (PCU325412325412) ↗ |
| Q1 2025 | Mar 30, 2025 | 915.34 | +0.8% | FRED (PCU325412325412) ↗ |
| Q4 2024 | Dec 29, 2024 | 918.11 | +2.4% | FRED (PCU325412325412) ↗ |
| Q3 2024 | Sep 29, 2024 | 917.27 | +2.3% | FRED (PCU325412325412) ↗ |
| Q2 2024 | Jun 30, 2024 | 914.37 | +2.3% | FRED (PCU325412325412) ↗ |
| Q1 2024 | Mar 31, 2024 | 907.84 | +1.8% | FRED (PCU325412325412) ↗ |
| Q4 2023 | Dec 31, 2023 | 896.32 | +2.9% | FRED (PCU325412325412) ↗ |
| Q3 2023 | Oct 1, 2023 | 896.48 | +3.3% | FRED (PCU325412325412) ↗ |
| Q2 2023 | Jul 2, 2023 | 894.12 | +4.5% | FRED (PCU325412325412) ↗ |
| Q1 2023 | Apr 2, 2023 | 891.95 | +5.3% | FRED (PCU325412325412) ↗ |
| Q4 2022 | Jan 1, 2023 | 871.34 | +4.4% | FRED (PCU325412325412) ↗ |
| Q3 2022 | Oct 2, 2022 | 868.21 | +4.2% | FRED (PCU325412325412) ↗ |
| Q2 2022 | Jul 3, 2022 | 855.31 | +2.4% | FRED (PCU325412325412) ↗ |
| Q1 2022 | Apr 3, 2022 | 847.33 | +1.6% | FRED (PCU325412325412) ↗ |
| Q4 2021 | Jan 2, 2022 | 834.30 | +1.7% | FRED (PCU325412325412) ↗ |
| Q3 2021 | Oct 3, 2021 | 832.91 | +1.2% | FRED (PCU325412325412) ↗ |
| Q2 2021 | Jul 4, 2021 | 834.97 | +1.2% | FRED (PCU325412325412) ↗ |
| Q1 2021 | Apr 4, 2021 | 833.83 | +0.9% | FRED (PCU325412325412) ↗ |
| Q4 2020 | Jan 3, 2021 | 820.63 | +1.2% | FRED (PCU325412325412) ↗ |
| Q3 2020 | Sep 27, 2020 | 823.03 | +1.2% | FRED (PCU325412325412) ↗ |
| Q2 2020 | Jun 28, 2020 | 824.67 | +1.7% | FRED (PCU325412325412) ↗ |
| Q1 2020 | Mar 29, 2020 | 826.17 | +2.0% | FRED (PCU325412325412) ↗ |
| Q4 2019 | Dec 29, 2019 | 810.63 | +2.2% | FRED (PCU325412325412) ↗ |
| Q3 2019 | Sep 29, 2019 | 813.07 | +3.1% | FRED (PCU325412325412) ↗ |
| Q2 2019 | Jun 30, 2019 | 810.50 | +3.6% | FRED (PCU325412325412) ↗ |
| Q1 2019 | Mar 31, 2019 | 810.17 | +3.5% | FRED (PCU325412325412) ↗ |
| Q4 2018 | Dec 30, 2018 | 792.97 | +3.5% | FRED (PCU325412325412) ↗ |
| Q3 2018 | Sep 30, 2018 | 788.63 | +4.1% | FRED (PCU325412325412) ↗ |
| Q2 2018 | Jul 1, 2018 | 782.50 | +4.0% | FRED (PCU325412325412) ↗ |
| Q1 2018 | Apr 1, 2018 | 783.07 | +4.7% | FRED (PCU325412325412) ↗ |
| Q4 2017 | Dec 31, 2017 | 765.83 | +6.0% | FRED (PCU325412325412) ↗ |
| Q3 2017 | Oct 1, 2017 | 757.73 | +5.4% | FRED (PCU325412325412) ↗ |
| Q2 2017 | Jul 2, 2017 | 752.60 | +6.0% | FRED (PCU325412325412) ↗ |
| Q1 2017 | Apr 2, 2017 | 748.10 | +6.1% | FRED (PCU325412325412) ↗ |
| Q4 2016 | Jan 1, 2017 | 722.37 | – | FRED (PCU325412325412) ↗ |
| Q3 2016 | Oct 2, 2016 | 719.03 | – | FRED (PCU325412325412) ↗ |
| Q2 2016 | Jul 3, 2016 | 709.93 | – | FRED (PCU325412325412) ↗ |
| Q1 2016 | Apr 3, 2016 | 705.17 | – | FRED (PCU325412325412) ↗ |
Breakdown
What makes up u.s. producer price index (ppi) — pharmaceutical preparation manufacturing (pcu325412325412)
- U.S. Consumer Price Index (CPI) — Medical Care Commodities (CUSR0000SAM1)404.94 · Q3 2026
- U.S. Consumer Price Index (CPI) — Medical Care Services (CUUR0000SAM2)654.45 · Q3 2026
- U.S. Retail Sales — Pharmacies & Drug Stores, Seasonally Adjusted ($M) (MRTSSM44611USS)–
- U.S. Retail Sales — Pharmacies & Drug Stores, Not Seasonally Adjusted ($M) (MRTSSM44611USN)–
- U.S. Real Personal Consumption Expenditures — Health Care, SAAR ($B) (DHLCRC1Q027SBEA)–
Cite this data
StockData. (2026). Johnson & Johnson U.S. Producer Price Index (PPI) — Pharmaceutical Preparation Manufacturing (PCU325412325412), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/fred_ppi_pharma
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.